Zinabu Teka1, Kasim Mohammed1, Gashu Workneh1, Zemichael Gizaw2. 1. Department of Statistics, College of Natural and Computational Sciences, University of Gondar, Gondar, Ethiopia. 2. Department of Environment and Occupational Health and Safety, Institute of Public Health College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. zemichael12@gmail.com.
Abstract
INTRODUCTION: The survival of HIV/AIDS patients on antiretroviral therapy (ART) is determined by a number of factors, including economic, demographic, behavioral, and institutional factors. Understanding the survival time and its trend is crucial to developing policies that will result in changes. The aim of this study was to compare the survival estimates of different subgroups and look into the predictors of HIV/AIDS patient survival. METHODS: A retrospective cohort study of HIV/AIDS patients receiving ART at the University of Gondar teaching hospital was carried out. To compare the survival of various groups, a Kaplan-Meier survival analysis was performed. The Cox proportional hazards model was used to identify factors influencing HIV/AIDS patient survival rates. RESULTS: In the current study, 5.91% of the 354 HIV/AIDS patients under ART follow-up were uncensored or died. Age (HR = 1.051) and lack of formal education (HR = 5.032) were associated with lower survival rate, whereas family size of one to two (HR = 0.167), three to four (HR = 0.120), no alcoholic consumption (HR = 0.294), no smoking and chat use (HR = 0.101), baseline weight (HR = 0.920), current weight (HR = 0.928), baseline CD4 cell count (HR = 0.990), baseline hemoglobin (HR = 0.800), and no TB diseases were associated with longer survival rate. CONCLUSIONS: Fewer deaths were reported in a study area due to high patient adherence, compared to previous similar studies. Age, educational status, family size, alcohol consumption, tobacco and chat usage, baseline and current weight, baseline CD4 cell count, baseline hemoglobin, and tuberculosis (TB) diseases were all significant predictors of survival of HIV/AIDS patients.
INTRODUCTION: The survival of HIV/AIDSpatients on antiretroviral therapy (ART) is determined by a number of factors, including economic, demographic, behavioral, and institutional factors. Understanding the survival time and its trend is crucial to developing policies that will result in changes. The aim of this study was to compare the survival estimates of different subgroups and look into the predictors of HIV/AIDSpatient survival. METHODS: A retrospective cohort study of HIV/AIDSpatients receiving ART at the University of Gondar teaching hospital was carried out. To compare the survival of various groups, a Kaplan-Meier survival analysis was performed. The Cox proportional hazards model was used to identify factors influencing HIV/AIDSpatient survival rates. RESULTS: In the current study, 5.91% of the 354 HIV/AIDSpatients under ART follow-up were uncensored or died. Age (HR = 1.051) and lack of formal education (HR = 5.032) were associated with lower survival rate, whereas family size of one to two (HR = 0.167), three to four (HR = 0.120), no alcoholic consumption (HR = 0.294), no smoking and chat use (HR = 0.101), baseline weight (HR = 0.920), current weight (HR = 0.928), baseline CD4 cell count (HR = 0.990), baseline hemoglobin (HR = 0.800), and no TB diseases were associated with longer survival rate. CONCLUSIONS: Fewer deaths were reported in a study area due to high patient adherence, compared to previous similar studies. Age, educational status, family size, alcohol consumption, tobacco and chat usage, baseline and current weight, baseline CD4 cell count, baseline hemoglobin, and tuberculosis (TB) diseases were all significant predictors of survival of HIV/AIDSpatients.
Authors: Julie Womack; Phyllis C Tien; Joseph Feldman; Ja Hyun Shin; Kristopher Fennie; Kathryn Anastos; Mardge H Cohen; Melanie C Bacon; Howard Minkoff Journal: Metabolism Date: 2007-07 Impact factor: 8.694
Authors: Rochelle P Walensky; Lindsey L Wolf; Robin Wood; Mariam O Fofana; Kenneth A Freedberg; Neil A Martinson; A David Paltiel; Xavier Anglaret; Milton C Weinstein; Elena Losina Journal: Ann Intern Med Date: 2009-07-20 Impact factor: 25.391
Authors: S Vella; M Giuliano; M Floridia; A Chiesi; C Tomino; A Seeber; S Barcherini; R Bucciardini; S Mariotti Journal: AIDS Date: 1995-01 Impact factor: 4.177
Authors: Clara Y Jones; Joseph W Hogan; Brad Snyder; Robert S Klein; Anne Rompalo; Paula Schuman; Charles C Carpenter Journal: Clin Infect Dis Date: 2003 Impact factor: 9.079
Authors: Frank J Palella; Maria Deloria-Knoll; Joan S Chmiel; Anne C Moorman; Kathleen C Wood; Alan E Greenberg; Scott D Holmberg Journal: Ann Intern Med Date: 2003-04-15 Impact factor: 25.391
Authors: Lien A Quach; Christine A Wanke; Christopher H Schmid; Sherwood L Gorbach; D Mkaya Mwamburi; Kenneth H Mayer; Donna Spiegelman; Alice M Tang Journal: Drug Alcohol Depend Date: 2008-02-19 Impact factor: 4.492
Authors: Anjali Sharma; Donald R Hoover; Qiuhu Shi; Deborah Gustafson; Michael W Plankey; Ronald C Hershow; Phyllis C Tien; Elizabeth T Golub; Kathryn Anastos Journal: PLoS One Date: 2015-12-23 Impact factor: 3.240